However, a dedicated trial of long-term prevention with clopidogrel on a background of aspirin in a broad population of patients with atherosclerotic disease or risk factors did not show a significant benefit
However, a dedicatedtrial of long-term prevention with clopidogrel ona background of aspirin in a broad population ofpatients with atherosclerotic disease or risk factorsdid not show a significant benefit